Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.

McAllister CS, Kagnoff MF.

Semin Immunopathol. 2012 Jul;34(4):581-600. doi: 10.1007/s00281-012-0318-8. Epub 2012 Jun 7. Review.

PMID:
22674144
2.

Treatment of celiac disease: from gluten-free diet to novel therapies.

Francavilla R, Cristofori F, Stella M, Borrelli G, Naspi G, Castellaneta S.

Minerva Pediatr. 2014 Oct;66(5):501-16. Review.

PMID:
24938882
3.

Celiac disease: risk assessment, diagnosis, and monitoring.

Setty M, Hormaza L, Guandalini S.

Mol Diagn Ther. 2008;12(5):289-98. Review.

PMID:
18803427
4.

Celiac disease: from pathogenesis to novel therapies.

Schuppan D, Junker Y, Barisani D.

Gastroenterology. 2009 Dec;137(6):1912-33. doi: 10.1053/j.gastro.2009.09.008. Epub 2009 Sep 18. Review.

PMID:
19766641
5.

Future therapeutic options for celiac disease.

Sollid LM, Khosla C.

Nat Clin Pract Gastroenterol Hepatol. 2005 Mar;2(3):140-7. Review.

PMID:
16265155
6.

New therapeutic strategies for celiac disease.

Lerner A.

Autoimmun Rev. 2010 Jan;9(3):144-7. doi: 10.1016/j.autrev.2009.05.002. Epub 2009 May 8. Review.

PMID:
19427921
7.

Celiac disease: prevention and treatment.

Selimoğlu MA, Karabiber H.

J Clin Gastroenterol. 2010 Jan;44(1):4-8. doi: 10.1097/MCG.0b013e3181b7ead2. Review.

PMID:
20027009
8.

In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.

Lindfors K, Rauhavirta T, Stenman S, Mäki M, Kaukinen K.

Exp Biol Med (Maywood). 2012 Feb;237(2):119-25. doi: 10.1258/ebm.2011.011294. Epub 2012 Jan 26. Review.

PMID:
22282398
9.

Investigational therapies for celiac disease.

Rodrigo L.

Expert Opin Investig Drugs. 2009 Dec;18(12):1865-73. doi: 10.1517/13543780903369333. Review.

PMID:
19938900
10.

Recent advances in the development of new treatments for celiac disease.

Lähdeaho ML, Lindfors K, Airaksinen L, Kaukinen K, Mäki M.

Expert Opin Biol Ther. 2012 Dec;12(12):1589-600. doi: 10.1517/14712598.2012.721766. Epub 2012 Aug 28. Review.

PMID:
22928821
11.

Gluten: a two-edged sword. Immunopathogenesis of celiac disease.

Koning F, Gilissen L, Wijmenga C.

Springer Semin Immunopathol. 2005 Sep;27(2):217-32. Epub 2005 Aug 10. Review.

PMID:
16091925
12.

Celiac disease: from gluten to autoimmunity.

Briani C, Samaroo D, Alaedini A.

Autoimmun Rev. 2008 Sep;7(8):644-50. doi: 10.1016/j.autrev.2008.05.006. Epub 2008 Jun 25. Review.

PMID:
18589004
13.

Novel perspectives in celiac disease therapy.

Sanz Y.

Mini Rev Med Chem. 2009 Mar;9(3):359-67. Review.

PMID:
19275728
14.

Future treatment strategies for celiac disease.

Lindfors K, Lähdeaho ML, Kalliokoski S, Kurppa K, Collin P, Mäki M, Kaukinen K.

Expert Opin Ther Targets. 2012 Jul;16(7):665-75. doi: 10.1517/14728222.2012.688808. Epub 2012 May 24. Review.

PMID:
22620264
15.

Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.

Ortiz-Sánchez JP, Cabrera-Chávez F, de la Barca AM.

Nutrients. 2013 Oct 21;5(10):4174-83. doi: 10.3390/nu5104174. Review.

16.

Celiac disease.

Williamson D, Marsh MN.

Mol Biotechnol. 2002 Nov;22(3):293-9. Review.

PMID:
12448883
17.

Advances in celiac disease and gluten-free diet.

Niewinski MM.

J Am Diet Assoc. 2008 Apr;108(4):661-72. doi: 10.1016/j.jada.2008.01.011. Review.

PMID:
18375224
18.

[The problems of organization of diet nutrition at the patients with gluten-sensitive enteropathy (celiac disease) in Russia].

Sabel'nikova EA, Parfenov AI, Krums LM, Belousova NL.

Eksp Klin Gastroenterol. 2010;(3):107-10. Review. Russian.

PMID:
20496799
19.

The molecular basis of celiac disease.

Koning F.

J Mol Recognit. 2003 Sep-Oct;16(5):333-6. Review.

PMID:
14523946
20.

[Celiac disease--the chameleon among the food intolerances].

Ströhle A, Wolters M, Hahn A.

Med Monatsschr Pharm. 2013 Oct;36(10):369-80; quiz 381-2. Review. German.

PMID:
24266248

Supplemental Content

Support Center